Patents by Inventor Manesh Dixit

Manesh Dixit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral controlled release dosage form
    Patent number: 9468633
    Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
    Type: Grant
    Filed: August 20, 2012
    Date of Patent: October 18, 2016
    Assignee: Andrx Pharmaceuticals, Inc.
    Inventors: Manesh Dixit, Chih-Ming Chen, Xiu Xiu Cheng, Jianbo Xie
  • Diltiazem controlled release formulation and method of manufacture
    Patent number: 8778395
    Abstract: A controlled release diltiazem dosage formulation comprising a plurality of diltiazem pellets and a gel-forming material where the time of maximum diltiazem blood plasma levels occurs more than 8 hours after administration and preferably more than 10 hours after administration.
    Type: Grant
    Filed: August 11, 2005
    Date of Patent: July 15, 2014
    Assignee: Andrx Labs, LLC
    Inventors: Xiu Xiu Cheng, Xiaohong Qi, Guohua Zhang, Manesh Dixit
  • Extended release venlafaxine formulation
    Patent number: 8668932
    Abstract: A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: March 11, 2014
    Assignee: Andrx Pharmaceuticals, LLC
    Inventors: Manesh Dixit, Xiu-Xiu Cheng, Avinash Nangia, Chin Ming Chen
  • ORAL CONTROLLED RELEASE DOSAGE FORM
    Publication number: 20130022678
    Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
    Type: Application
    Filed: August 20, 2012
    Publication date: January 24, 2013
    Applicant: ANDRX PHARMACEUTICALS, INC.
    Inventors: Manesh Dixit, Chih-Ming Chen, Xiu Xiu Cheng, Jianbo Xie
  • Oral controlled release dosage form
    Patent number: 8252327
    Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
    Type: Grant
    Filed: July 11, 2011
    Date of Patent: August 28, 2012
    Assignee: Andrx Pharmaceuticals, Inc.
    Inventors: Manesh Dixit, Chih-Ming Chen, Xiu-Xiu Cheng, Jianbo Xie
  • ORAL CONTROLLED RELEASE DOSAGE FORM
    Publication number: 20110268799
    Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
    Type: Application
    Filed: July 11, 2011
    Publication date: November 3, 2011
    Applicant: ANDRX PHARMACEUTICALS, INC.
    Inventors: Manesh Dixit, Chih-Ming Chen, Xiu-Xiu Cheng, Jianbo Xie
  • Oral controlled release dosage form
    Patent number: 7988993
    Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
    Type: Grant
    Filed: December 2, 2003
    Date of Patent: August 2, 2011
    Assignee: Andrx Pharmaceuticals, Inc.
    Inventors: Manesh Dixit, Chih-Ming Chen, Xiu Xiu Cheng, Jianbo Xie
  • EXTENDED RELEASE VENLAFAXINE FORMULATION
    Publication number: 20110165234
    Abstract: A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
    Type: Application
    Filed: March 18, 2011
    Publication date: July 7, 2011
    Applicant: ANDRX PHARMACEUTICALS, LLC
    Inventors: Manesh Dixit, Xiu-Xiu Cheng, Avinash Nangia, Chin Ming Chen
  • Extended release venlafaxine formulation
    Patent number: 7931915
    Abstract: A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: April 26, 2011
    Assignee: Andrx Pharmaceuticals, LLC
    Inventors: Manesh Dixit, Xiu-Xiu Cheng, Avinash Nangia, Chih Ming Chen
  • Extended release venlafaxine formulation
    Publication number: 20090081286
    Abstract: A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
    Type: Application
    Filed: November 19, 2008
    Publication date: March 26, 2009
    Inventors: Manesh Dixit, Xiu-Xiu Cheng, Avinash Nangia, Chih Ming Chen
  • Extended release venlafaxine formulation
    Patent number: 7470435
    Abstract: A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: December 30, 2008
    Assignee: Andrx Pharmaceuticals, LLC
    Inventors: Manesh Dixit, Xiu-Xiu Cheng, Avinash Nangia, Chih Ming Chen
  • Diltiazem controlled release formulation and method of manufacture
    Publication number: 20070036856
    Abstract: A controlled release diltiazem dosage formulation comprising a plurality of diltiazem pellets and a gel-forming material where the time of maximum diltiazem blood plasma levels occurs more than 8 hours after administration and preferably more than 10 hours after administration.
    Type: Application
    Filed: August 11, 2005
    Publication date: February 15, 2007
    Inventors: Xiu Cheng, Xiaohong Qi, Guohua Zhang, Manesh Dixit
  • Extended release venlafaxine formulation
    Publication number: 20050106248
    Abstract: A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
    Type: Application
    Filed: November 17, 2003
    Publication date: May 19, 2005
    Inventors: Manesh Dixit, Xiu-Xiu Cheng, Avinash Nangia, Chih Chen
  • Oral controlled release dosage form
    Publication number: 20040156896
    Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
    Type: Application
    Filed: December 2, 2003
    Publication date: August 12, 2004
    Inventors: Manesh Dixit, Chih-Ming Chen, Xiu Xiu Cheng, Jianbo Xie